These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24081522)

  • 1. Extracellular loop 3 of the noradrenaline transporter contributes to substrate and inhibitor selectivity.
    Lynagh T; Khamu TS; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jan; 387(1):95-107. PubMed ID: 24081522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the functional roles of the MELAL and GQXXRXG motifs of the human noradrenaline transporter using cysteine mutants.
    Sucic S; Bryan-Lluka LJ
    Eur J Pharmacol; 2007 Feb; 556(1-3):27-35. PubMed ID: 17141753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters.
    Andersen J; Stuhr-Hansen N; Zachariassen L; Toubro S; Hansen SM; Eildal JN; Bond AD; Bøgesø KP; Bang-Andersen B; Kristensen AS; Strømgaard K
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12137-42. PubMed ID: 21730142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for selective serotonin reuptake inhibition by the antidepressant agent fluoxetine (Prozac).
    Andersen J; Stuhr-Hansen N; Zachariassen LG; Koldsø H; Schiøtt B; Strømgaard K; Kristensen AS
    Mol Pharmacol; 2014 May; 85(5):703-14. PubMed ID: 24516100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology.
    Paczkowski FA; Bryan-Lluka LJ
    Brain Res Mol Brain Res; 2001 Dec; 97(1):32-42. PubMed ID: 11744160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the conserved GXXXRXG motif in the expression and function of the human norepinephrine transporter.
    Sucic S; Bryan-Lluka LJ
    Brain Res Mol Brain Res; 2002 Dec; 108(1-2):40-50. PubMed ID: 12480177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of proline residues in the expression and function of the human noradrenaline transporter.
    Paczkowski FA; Bryan-Lluka LJ
    J Neurochem; 2004 Jan; 88(1):203-11. PubMed ID: 14675164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles.
    Mandela P; Chandley M; Xu YY; Zhu MY; Ordway GA
    Neurochem Int; 2010; 56(6-7):760-7. PubMed ID: 20176067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulatory effects of the soy phytoestrogen genistein on noradrenaline transporter and serotonin transporter activity.
    Toyohira Y; Ueno S; Tsutsui M; Itoh H; Sakai N; Saito N; Takahashi K; Yanagihara N
    Mol Nutr Food Res; 2010 Apr; 54(4):516-24. PubMed ID: 20087855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibitory effects of drugs acting at the noradrenaline and 5-hydroxytryptamine transporters in rat and human neocortical synaptosomes.
    Mantovani M; Dooley DJ; Weyerbrock A; Jackisch R; Feuerstein TJ
    Br J Pharmacol; 2009 Dec; 158(7):1848-56. PubMed ID: 19912224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding site residues control inhibitor selectivity in the human norepinephrine transporter but not in the human dopamine transporter.
    Andersen J; Ringsted KB; Bang-Andersen B; Strømgaard K; Kristensen AS
    Sci Rep; 2015 Oct; 5():15650. PubMed ID: 26503701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.
    Henry LK; Field JR; Adkins EM; Parnas ML; Vaughan RA; Zou MF; Newman AH; Blakely RD
    J Biol Chem; 2006 Jan; 281(4):2012-23. PubMed ID: 16272152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of norepinephrine transporters on PC12 cells by transporter inhibitors.
    Zhu MY; Ordway GA
    J Neurochem; 1997 Jan; 68(1):134-41. PubMed ID: 8978719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of [³H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive.
    Zhen J; Ali S; Dutta AK; Reith ME
    J Neurosci Methods; 2012 Jan; 203(1):19-27. PubMed ID: 21933682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A second extracellular site is required for norepinephrine transport by the human norepinephrine transporter.
    Wang CI; Shaikh NH; Ramu S; Lewis RJ
    Mol Pharmacol; 2012 Nov; 82(5):898-909. PubMed ID: 22874414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket.
    Sørensen L; Andersen J; Thomsen M; Hansen SM; Zhao X; Sandelin A; Strømgaard K; Kristensen AS
    J Biol Chem; 2012 Dec; 287(52):43694-707. PubMed ID: 23086945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional significance of a highly conserved glutamate residue of the human noradrenaline transporter.
    Sucic S; Paczkowski FA; Runkel F; Bönisch H; Bryan-Lluka LJ
    J Neurochem; 2002 Apr; 81(2):344-54. PubMed ID: 12064482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the human norepinephrine transporter by cocaine and amphetamine.
    Zhu MY; Shamburger S; Li J; Ordway GA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):951-9. PubMed ID: 11082428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake.
    Zhou Z; Zhen J; Karpowich NK; Goetz RM; Law CJ; Reith ME; Wang DN
    Science; 2007 Sep; 317(5843):1390-3. PubMed ID: 17690258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontogeny of Norepinephrine Transporter Expression and Antidepressant-Like Response to Desipramine in Wild-Type and Serotonin Transporter Mutant Mice.
    Mitchell NC; Bowman MA; Gould GG; Koek W; Daws LC
    J Pharmacol Exp Ther; 2017 Jan; 360(1):84-94. PubMed ID: 27831486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.